mirtazapine has been researched along with Appetite Disorders in 11 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This report presents the beneficial effect of low-dose mirtazapine added onto selective serotonin reuptake inhibitors in the treatment of the symptoms of severe nausea, insomnia and loss of appetite accompanying psychiatric disorders during pregnancy, which is an important problem in clinical practice." | 7.79 | Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases. ( Uguz, F, 2013) |
| " This report presents the beneficial effect of low-dose mirtazapine added onto selective serotonin reuptake inhibitors in the treatment of the symptoms of severe nausea, insomnia and loss of appetite accompanying psychiatric disorders during pregnancy, which is an important problem in clinical practice." | 3.79 | Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases. ( Uguz, F, 2013) |
| "Mirtazapine is a noradrenergic and specific serotonergic antidepressant, characterized by a unique pharmacologic profile, favorable pharmacokinetics, and proven efficacy and safety." | 2.40 | Mirtazapine: clinical advantages in the treatment of depression. ( Burrows, GD; Kremer, CM, 1997) |
| "Mirtazapine was administered to 50 cancer patients with digestive symptoms in palliative care, and the data were retrospectively examined." | 1.40 | [Effectiveness of mirtazapine for digestive symptoms in palliative care - retrospective study of 50 cases]. ( Imai, E; Nishimura, D; Shibahara, H; Tokura, Y; Uematsu, N, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Naviaux, AF | 1 |
| Ferrari, V | 1 |
| Fontecedro, E | 1 |
| Balestrieri, M | 1 |
| Sambataro, F | 1 |
| Gray, E | 1 |
| Chen, T | 1 |
| Menzel, J | 1 |
| Schwartz, T | 1 |
| Kaye, WH | 1 |
| Akbas, B | 1 |
| Akca, OF | 1 |
| Lopes, R | 1 |
| Melo, R | 1 |
| Dias Pereira, B | 1 |
| Shinith, D | 1 |
| Mathilakath, A | 1 |
| Kim, DI | 1 |
| Patel, B | 1 |
| Shibahara, H | 1 |
| Uematsu, N | 1 |
| Imai, E | 1 |
| Tokura, Y | 1 |
| Nishimura, D | 1 |
| Jeong, JH | 1 |
| Bahk, WM | 1 |
| Uguz, F | 1 |
| Burrows, GD | 1 |
| Kremer, CM | 1 |
| Carpenter, LL | 1 |
| Leon, Z | 1 |
| Yasmin, S | 1 |
| Price, LH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety Analyses of Mirtazapine in the Treatment of Malignant Tumor Related Depression: A Phase II, Placebo-controlled, Randomized, Double-blinded Clinical Trial in Advanced Non-small Cell Lung Cancer Patients[NCT02650544] | Phase 2 | 236 participants (Anticipated) | Interventional | 2015-12-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for mirtazapine and Appetite Disorders
| Article | Year |
|---|---|
Management of ARFID (Avoidant Restrictive Food Intake Disorder) in a 12-year-old on a Paediatric Ward in a General Hospital: Use of Mirtazapine, Partial Hospitalisation Model and Family Based Therapy.
Topics: Child; Day Care, Medical; Family; Feeding and Eating Disorders; Female; Hospitalization; Hospitals, | 2019 |
Mirtazapine: clinical advantages in the treatment of depression.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Clomipramine | 1997 |
1 trial available for mirtazapine and Appetite Disorders
| Article | Year |
|---|---|
Clinical experience with mirtazapine in the treatment of panic disorder.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Drug Administration | 1999 |
8 other studies available for mirtazapine and Appetite Disorders
| Article | Year |
|---|---|
A Case of Visual Illusions Secondary to Mirtazapine Treatment.
Topics: Aged, 80 and over; Feeding and Eating Disorders; Hallucinations; Humans; Illusions; Male; Mirtazapin | 2020 |
Mirtazapine and Weight Gain in Avoidant and Restrictive Food Intake Disorder.
Topics: Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Child; Feeding and Eating Disorders; Fe | 2018 |
Treatment of a Child with Autism Spectrum Disorder and Food Refusal Due to Restricted and Repetitive Behaviors.
Topics: Aggression; Aripiprazole; Autism Spectrum Disorder; Child; Feeding and Eating Disorders; Humans; Mal | 2018 |
Orthorexia nervosa and comorbid depression successfully treated with mirtazapine: a case report.
Topics: Adolescent; Antidepressive Agents; Depressive Disorder, Major; Feeding and Eating Disorders; Female; | 2020 |
Sleep-related eating disorder with mirtazapine.
Topics: Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Feeding and Eating Disorders; F | 2018 |
[Effectiveness of mirtazapine for digestive symptoms in palliative care - retrospective study of 50 cases].
Topics: Adult; Aged; Aged, 80 and over; Feeding and Eating Disorders; Female; Humans; Male; Mianserin; Middl | 2014 |
Sleep-related eating disorder associated with mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Feeding and Eating Disorders; Female; Humans; Mianserin; Mirtazapi | 2014 |
Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Dose-Response Relationship, Drug; Feeding and E | 2013 |